CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,297 | $83.25 | $274K | 39,859 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −2,745 | $84.28 | $231K | 37,114 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,175 | $85.44 | $271K | 33,939 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −5,855 | $86.34 | $506K | 28,084 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −373 | $87.30 | $33K | 27,711 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −300 | $88.70 | $27K | 27,411 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −1,600 | $90.13 | $144K | 25,811 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −1,900 | $91.27 | $173K | 23,911 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −1,000 | $92.28 | $92K | 22,911 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −9,628 | $93.33 | $899K | 13,283 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −4,511 | $94.55 | $427K | 8,772 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,173 | $95.51 | $303K | 5,599 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,174 | $96.29 | $306K | 2,425 |
| 2025-04-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −705 | $97.24 | $69K | 1,720 |
| 2025-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +16,250 | 24,742 | ||
| 2025-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −8,418 | $95.66 | $805K | 16,324 |
| 2025-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −328 | $94.40 | $31K | 15,996 |
| 2025-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −16,250 | 48,750 | ||
| 2025-03-26 | Stueland Katherine Chief Executive Officer | Option exercise | +80,000 | 94,865 | ||
| 2025-03-26 | Stueland Katherine Chief Executive Officer | Sale | −44,801 | $95.66 | $4.3M | 50,064 |
Page 20 of 23 · 450 trades